Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Ted Bosworth

    News

    More on GRADE: Cognitive deficits linked to CV risk factors in T2D

    Author:
    Ted Bosworth
    Publish date: July 27, 2021

    Hyperlipidemia and hypertension predict modest cognitive impairment even in diabetes of limited duration, but one expert urges caution: “The...

    • Read More

    News

    Medicare rules for CPAP penalize low-income patients for nonadherence

    Author:
    Ted Bosworth
    Publish date: July 21, 2021

    Adherence studies show a steady climb in adherence in all income groups initially, but “right at 90 days, there...

    • Read More

    News

    PCI after TAVR mostly succeeds, some risks identified

    Author:
    Ted Bosworth
    Publish date: July 20, 2021

    In a relatively large-scale registry analysis, angiography was performed successfully after TAVR in most cases.

    • Read More

    News

    DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry

    Author:
    Ted Bosworth
    Publish date: July 16, 2021

    Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.

    • Read More

    News

    Telemedicine is poised to drive new models of care

    Author:
    Ted Bosworth
    Publish date: July 13, 2021

    The effort to bring permanent coverage of telehealth services “the shared responsibility of every medical...

    • Read More

    News

    Patients’ sexual problems: Be proactive, make discussions routine

    Author:
    Ted Bosworth
    Publish date: June 29, 2021

    Elicit information about sexual health in the context of inquiring about other clinical issues, advised Dr. Anita H. Clayton.

    • Read More

    News

    Maintain OMT for 5 years after revascularization, boost survival at 10 years: SYNTAXES

    Author:
    Ted Bosworth
    Publish date: June 29, 2021

    Sustained optimal drug therapy after PCI or CABG is found to have major impact on mortality at 10 years, in an analysis of SYNTAX trial data.

    • Read More

    News

    Guidance provided for telepsychiatry in tardive dyskinesia

    Author:
    Ted Bosworth
    Publish date: June 25, 2021

    An in-person visit is preferred for initial evaluation and diagnosis of TD, Dr. Rif S. El-Mallakh reported.

    • Read More

    News

    AI-based software demonstrates accuracy in diagnosis of autism

    Author:
    Ted Bosworth
    Publish date: June 25, 2021

    “The lack of diagnostic tools for ASD in primary care settings contributes to an average delay of 3 years between first parental concern and...

    • Read More

    News

    Risk to infant may warrant drug treatment for postpartum depression

    Author:
    Ted Bosworth
    Publish date: June 24, 2021

    Persistent postpartum depression are associated with a more than fourfold risk of behavioral problems at the age of 3.5 years, Dr. Neha Hudepohl...

    • Read More

    News

    Long-acting injectable antipsychotics deserve first-line consideration

    Author:
    Ted Bosworth
    Publish date: June 21, 2021

    Circumventing large risks of nonadherence, long-acting injectables should be an option considered routinely, said Dr. Diana Perkins.

    • Read More

    News

    Telemedicine is poised to drive new models of care

    Author:
    Ted Bosworth
    Publish date: June 19, 2021

    A much larger role for telemedicine in clinical care appears inevitable after the COVID-19 pandemic experience.

    • Read More

    News

    Emerging drugs for schizophrenia targeting negative symptoms

    Author:
    Ted Bosworth
    Publish date: June 17, 2021

    Several antipsychotics that show efficacy against negative symptoms are in advanced stages of development, said Dr. Henry A. Nasrallah.

    • Read More

    News

    Western and proinflammatory diets are important drivers of gout risk

    Author:
    Ted Bosworth
    Publish date: June 16, 2021

    Western and proinflammatory diets are associated with increased risk of gout independent of other factors.

    • Read More

    News

    Secukinumab provides clinical benefit in phase 3 juvenile arthritis trial

    Author:
    Ted Bosworth
    Publish date: June 15, 2021

    Phase 3 trial shows secukinumab is effective for enthesitis-related arthritis and juvenile psoriatic arthritis in children.

    • Read More

    Pages

    • « first
    • …
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery